The glymphatic system (en) during inflammation

FLH Mogensen, C Delle, M Nedergaard - International journal of …, 2021 - mdpi.com
The glymphatic system is a fluid-transport system that accesses all regions of the brain. It
facilitates the exchange of cerebrospinal fluid and interstitial fluid and clears waste from the …

Next-generation nanomaterials: advancing ocular anti-inflammatory drug therapy

J Wei, J Mu, Y Tang, D Qin, J Duan, A Wu - Journal of nanobiotechnology, 2023 - Springer
Ophthalmic inflammatory diseases, including conjunctivitis, keratitis, uveitis, scleritis, and
related conditions, pose considerable challenges to effective management and treatment …

Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised …

C Zhang, M Zhang, W Qiu, H Ma, X Zhang… - The Lancet …, 2020 - thelancet.com
Background Azathioprine is used as a first-line treatment to prevent relapses of
neuromyelitis optica spectrum disorder (NMOSD). Tocilizumab has been reported to reduce …

Neuro-Behcet's disease: an update on diagnosis, differential diagnoses, and treatment

A Borhani-Haghighi, B Kardeh, S Banerjee… - Multiple sclerosis and …, 2020 - Elsevier
Neuro-Behcet's disease (NBD) is defined as a combination of neurologic symptoms and/or
signs in a patient with Behcet's disease (BD). Relevant syndromes include brainstem …

Critical review: typical and atypical optic neuritis

A Abel, C McClelland, MS Lee - Survey of ophthalmology, 2019 - Elsevier
Typical optic neuritis is an idiopathic demyelinating condition that is often associated with
multiple sclerosis. This has been well characterized and has an excellent prognosis …

A comprehensive review of the advances in neuromyelitis optica spectrum disorder

P Siriratnam, S Huda, H Butzkueven… - Autoimmunity …, 2023 - Elsevier
Neuromyelitis optica spectrum disorder (NMOSD) is a rare relapsing neuroinflammatory
autoimmune astrocytopathy, with a predilection for the optic nerves and spinal cord. Most …

Serious safety events in rituximab‐treated multiple sclerosis and related disorders

BL Vollmer, AI Wallach, JR Corboy… - Annals of Clinical …, 2020 - Wiley Online Library
Introduction Studies investigating rates and risk factors for serious safety events (SSEs)
during rituximab treatment of multiple sclerosis (MS), neuromyelitis optica spectrum …

Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy

C Betterle, J Furmaniak, C Sabbadin, C Scaroni… - Journal of …, 2023 - Springer
Background The number of recognised distinct autoimmune diseases (AIDs) has
progressively increased over the years with more than 100 being reported today. The …

Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: a national population-based study

DC Tian, Z Li, M Yuan, C Zhang, H Gu… - The Lancet Regional …, 2020 - thelancet.com
Abstract Background Neuromyelitis Optica Spectrum Disorder (NMOSD) is an inflammatory
disease of the central nervous system with preferential involvement of the optic nerve and …

Pain in NMOSD and MOGAD: a systematic literature review of pathophysiology, symptoms, and current treatment strategies

S Asseyer, G Cooper, F Paul - Frontiers in Neurology, 2020 - frontiersin.org
Neuromyelitis optica spectrum disorders (NMOSDs) and myelin oligodendrocyte
glycoprotein-antibody-associated disease (MOGAD) are autoimmune inflammatory …